炎症性細胞死と白血病の治療
Saqib Ishaq1, Sajida Afzal2, Shabir Ahmad Usmani3
1Guangdong Provincial Key Laboratory of System Biology and Synthetic Biology for Urogenital Tumors, School of Basic Medicine, Shenzhen University Medical School, Shenzhen University (SZU), Guangdong, Guangdong 518060, China; Department of Computer Sciences and Bioinformatics, Khushal Khan Khattak University, Karak, Karak 27200, Pakistan.
Critical reviews in oncology/hematology
|August 23, 2025
まとめ
ピロプトーシス,ネクロプトーシス,フェロプトーシスなどの炎症性細胞死経路は白血病の発達と抵抗を制御する上で極めて重要です. これらのメカニズムを理解することで 血液がんの新たな治療戦略が生まれます
科学分野:
- 腫瘍学
- 免疫学
- 細胞生物学
背景:
- 炎症性細胞死は 免疫監視と組織ホメオスタシスに不可欠です
- 白血病は,異常な造血幹細胞と祖先細胞から発生し,様々なサブタイプがあります.
- ピロプトーシス,ネクロプトーシス,フェロプトーシスを含む炎症性細胞死亡のメカニズムは,白血病の進行と治療に影響します.
研究 の 目的:
- 炎症性細胞死に焦点を当てた白血病の治療戦略をレビューする.
- 組み合わせた治療法,免疫反応の修正,そして個別化された治療アプローチを検証する.
主な方法:
- 白血病における炎症性細胞死亡メカニズムに関する科学文献のレビュー
- 白血病の文脈におけるピロプトーシス,ネクロプトーシス,フェロプトーシス経路の分析.
- これらの経路を対象とした現在および新興の治療戦略の評価
主要な成果:
- カスパースの活性化によって調節されるピロプトーシスは,白血病を抑制または促進することができます.
- RIPK1とRIPK3を含む死滅は,アポトーシス抵抗性白血病細胞の代替死滅経路を提供します.
- 鉄に依存するプロセスであるフェロプトーシスは 治療に抵抗する白血病の治療に 新しい戦略を提示しています
結論:
- 炎症性細胞死経路をターゲットにすることで 白血病の治療を進める大きな可能性を秘めています
- 免疫反応を調節する 組み合わせた治療法と個別化されたアプローチは 治療抵抗性の克服の鍵です
- 分子経路制御に関するさらなる研究は,血液がんの革新的な治療法の開発を推進します.
関連する概念動画
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Inflammation
55.1K
Overview
55.1K
Overview of Cell Death
7.7K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.7K
Disorders of Leukocytes
1.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.1K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


